CorriXR Therapeutics
PrivateLast Round
Series A
Aug 19, 2025
Total Funding Raised
$11.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CorriXR Therapeutics is a biotechnology company that develops genetic medicines using a CRISPR-based gene editing platform to treat drug-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorriXR Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CorriXR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 19, 2025 | ||||
| Seed | Jan 22, 2024 | ||||
| Seed | Oct 11, 2022 |
Key People
Founding team and executive leadership
CorriXR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delaware Division of Small Business | Series A |
| Cortado Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Developing an inhaler device for cancer treatment delivery.
- Dec 2, 2025
Partnered with InhaTarget Therapeutics and Merxin Ltd.
CorriXR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CorriXR Therapeutics's valuation, stock price, and market status.